Literature DB >> 18709518

Parathyroid hormone analogues in the therapy of osteoporosis.

Markus Müller1, Peter Pietschmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18709518     DOI： 10.1007/s00508-008-0999-0

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  18 in total

Review 1.  Circulating PTH molecular forms: what we know and what we don't.

Authors:  P D'Amour
Journal:  Kidney Int Suppl       Date:  2006-07       Impact factor: 10.545

2.  Daily and cyclic parathyroid hormone in women receiving alendronate.

Authors:  Felicia Cosman; Jeri Nieves; Marsha Zion; Lillian Woelfert; Marjorie Luckey; Robert Lindsay
Journal:  N Engl J Med       Date:  2005-08-11       Impact factor: 91.245

3.  One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.

Authors:  Dennis M Black; John P Bilezikian; Kristine E Ensrud; Susan L Greenspan; Lisa Palermo; Trisha Hue; Thomas F Lang; Joan A McGowan; Clifford J Rosen
Journal:  N Engl J Med       Date:  2005-08-11       Impact factor: 91.245

4.  Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong?

Authors:  Susan B Jaglal; Iris Weller; Muhammad Mamdani; Gillian Hawker; Hans Kreder; Liisa Jaakkimainen; Jonathan D Adachi
Journal:  J Bone Miner Res       Date:  2004-12-20       Impact factor: 6.741

5.  Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized cynomolgus macaques.

Authors:  M Sato; M Westmore; J Clendenon; S Smith; B Hannum; G Q Zeng; R Brommage; C H Turner
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

6.  Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis).

Authors:  C P Jerome; D B Burr; T Van Bibber; J M Hock; R Brommage
Journal:  Bone       Date:  2001-02       Impact factor: 4.398

Review 7.  Treatment and prevention of osteoporosis.

Authors:  Jaroslav Blahos
Journal:  Wien Med Wochenschr       Date:  2007

8.  The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.

Authors:  Dennis M Black; Susan L Greenspan; Kristine E Ensrud; Lisa Palermo; Joan A McGowan; Thomas F Lang; Patrick Garnero; Mary L Bouxsein; John P Bilezikian; Clifford J Rosen
Journal:  N Engl J Med       Date:  2003-09-20       Impact factor: 91.245

9.  Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis.

Authors:  Robert Lindsay; Wim H Scheele; Robert Neer; Gerhardt Pohl; Silvano Adami; Carlos Mautalen; Jean-Yves Reginster; Jan J Stepan; Stephen L Myers; Bruce H Mitlak
Journal:  Arch Intern Med       Date:  2004-10-11

10.  Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.

Authors:  Bruce Ettinger; Javier San Martin; Gerald Crans; Imre Pavo
Journal:  J Bone Miner Res       Date:  2004-01-19       Impact factor: 6.741
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.